Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$9.45 USD
-0.05 (-0.53%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $9.44 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Avid Bioservices, Inc falls in the month of April .
All items in Millions except EPS data.
4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | |
---|---|---|---|---|---|
Sales | 140 | 149 | 120 | 96 | 60 |
Cost Of Goods | NA | 118 | 83 | 67 | 56 |
Gross Profit | NA | 31 | 37 | 29 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 28 | 21 | 17 | 15 |
Income After Depreciation & Amortization | 0 | 4 | 15 | 12 | -11 |
Non-Operating Income | NA | 1 | 0 | 0 | 0 |
Interest Expense | NA | 3 | 3 | 1 | 0 |
Pretax Income | NA | 2 | 13 | 11 | -10 |
Income Taxes | NA | 1 | -115 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -141 | 1 | 128 | 11 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -141 | 1 | 128 | 11 | -10 |
Depreciation Footnote | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 12 | 21 | 17 | -8 |
Depreciation & Amortization (Cash Flow) | NA | 8 | 6 | 4 | 3 |
Income After Depreciation & Amortization | 0 | 4 | 15 | 12 | -11 |
Earnings Per Share Data | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Average Shares | 63.20 | 63.78 | 70.47 | 59.43 | 56.33 |
Diluted EPS Before Non-Recurring Items | -0.35 | 0.02 | 0.27 | 0.06 | -0.27 |
Diluted Net EPS (GAAP) | -2.23 | 0.01 | 1.84 | 0.06 | -0.27 |
Fiscal Year end for Avid Bioservices, Inc falls in the month of April .
All items in Millions except EPS data.
4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | |
---|---|---|---|---|---|
Sales | 42.98 | 33.82 | 25.40 | 37.73 | 39.80 |
Cost Of Goods | NA | 31.43 | 30.06 | 33.63 | 31.41 |
Gross Profit | NA | 2.38 | -4.66 | 4.10 | 8.39 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.38 | 6.56 | 6.26 | 7.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -4.00 | -11.22 | -2.16 | 0.83 |
Non-Operating Income | NA | -2.18 | 0.14 | 0.26 | 0.43 |
Interest Expense | NA | 0.88 | 0.81 | 0.78 | 0.76 |
Pretax Income | NA | -7.06 | -11.89 | -2.68 | 0.45 |
Income Taxes | NA | -1.05 | -2.38 | -0.59 | 0.76 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -123.10 | -6.01 | -9.51 | -2.09 | -0.31 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -123.10 | -6.01 | -9.51 | -2.09 | -0.31 |
Earnings Per Share Data | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 |
---|---|---|---|---|---|
Average Shares | 63.50 | 63.32 | 63.15 | 62.84 | 62.59 |
Diluted EPS Before Non-Recurring Items | -0.07 | -0.08 | -0.15 | -0.03 | 0.00 |
Diluted Net EPS (GAAP) | -1.94 | -0.09 | -0.15 | -0.03 | 0.00 |